News
To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac (www.adaptvac.com) and Bavarian Nordic (OMX: BAVA, OTC: BVNRY). …
Read MoreVarCT Diagnostics has received a EUR 2M R&D grant from the Danish Innovation Foundation to advance Early Diagnosis of Cancer by Sensitive Detection of Circulating Tumor Cells (prEDICT). VarCT Diagnostics ApS Ole Maaløes Vej 3 DK-2200 Copenhagen N CVR: 38733567 T: +45 78 70 19 00 info@varctdiagnostics.com
Read MoreVarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business. VarCT Diagnostics ApS Ole Maaløes Vej 3 DK-2200 Copenhagen N CVR: 38733567 T: +45 78 70 19 00 info@varctdiagnostics.com
Read MoreVarCT Diagnostics ApS
Ole Maaløes Vej 3
DK-2200 Copenhagen N
CVR: 38733567
T: +45 78 70 19 00
info@varctdiagnostics.com